Disruption of tight junctions during polymicrobial sepsis in vivo

Journal of Pathology

Volumn 218, Issue 2, 2009, Pages 210-221

  Li, Qiurong ^a,b   Zhang, Qiang ^a,b   Wang, Chenyang ^a   Liu, Xiaoxiang ^c   Li, Ning ^a   Li, Jieshou ^a  

^a JINLING HOSPITAL   (China)

^b NANJING UNIVERSITY   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Barrier function dysfunction; Sepsis; Tight junction; Tight junction proteins

Indexed keywords

CAVEOLIN 1; CLAUDIN 1; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 8; OCCLUDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEMALE; INTESTINE BRUSH BORDER; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; TIGHT JUNCTION; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; COLON; FEMALE; INTESTINAL ABSORPTION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; SEPSIS; TIGHT JUNCTIONS; TIME FACTORS;

EID: 66849089711     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2525     Document Type: Article

References (29)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310. (Pubitemid 32641789)
2. Nieuwenhuijzen GA, Deitch EA, Goris RJ. The relationship between gut-derived bacteria and the development of the multiple organ dysfunction syndrome. J Anat 1996;189:537-548. (Pubitemid 27011007)
3. Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol 1998;60:121-142. (Pubitemid 28157867)
4. Mitic LL, Van Itallie CM, Anderson JM, Schneeberger EE, Fanning AS. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000;279:G250-G254.
5. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol Gastrointest Liver Physiol 1995;269:G467-G475.
6. Ma TY. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 1997;214:318-327. (Pubitemid 27212856)
7. Söderholm JD, Perdue MH. Stress and the gastrointestinal tract II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 2001;280:G7-G13. (Pubitemid 32466869)
8. Furuse M, Fujimoto K, Sato N, Hirase T, Tsukita S. Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures. J Cell Sci 1996;109:429-435. (Pubitemid 26057662)
9. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Sci 1993;123:1777-1788. (Pubitemid 24012933)
10. Noda A, Kubo A, Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Sci 2002;156:1099-1111. (Pubitemid 34839858)
11. Stevenson BR, Anderson JM, Goodenough DA, Mooseker MS. Tight junction structure and ZO-1 content are identical in two strains of Madin-Darby canine kidney cells which differ in transepithelial electrical resistance. J Cell Biol 1988;107:2401-2408. (Pubitemid 19015117)
12. Kompan L, Kompan D. Importance of increased intestinal permeability after multiple injuries. Eur J Surg 2001;167:570-574. (Pubitemid 32977180)
13. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999;116:301-309. (Pubitemid 29055352)
14. Li QR, Zhang Q, Zhang M, Wang CY, Zhu ZX, Li N, et al. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J 2008;275:411-420.
15. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-507.
16. Muza-Moons MM, Schneeberger EE, Hecht GA. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junction strands in the lateral membrane of intestinal epithelial cells. Cell Microbiol 2004;6:783-793. (Pubitemid 39077384)
17. Li QR, Zhang Q, Wang M, Zhao SM, Ma J, Luo N, et al. Interferon-γ and tumor necrosis factor-α disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008;126:67-80. (Pubitemid 350266450)
18. Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin-2, -5 and -8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007;56:61-72. (Pubitemid 46044890)
19. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, et al. Tight junctions are membrane microdomains. J Cell Sci 2000;113:1771-1781. (Pubitemid 30333126)
20. Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 2001;69:1329-1336. (Pubitemid 32187577)
21. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980;29:189-201. (Pubitemid 10039498)
22. Chung C-S, Wang WY, Chaudry IH, Ayala A. Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am J Physiol Gastrointest Liver Physiol 2001;280:G812-G818. (Pubitemid 32436017)
23. Guttman JA, Samji FN, Li YL, Wayne A, Finlay BB. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infect Immun 2006;74:6075-6084. (Pubitemid 44657385)
24. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001;120:411-422. (Pubitemid 32147639)
25. Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 2004;53:1295-1302. (Pubitemid 39120115)
26. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, et al. Molecular signatures of sepsis multi-organ gene expression profiles of systemic inflammation. Am J Pathol 2001;159:1199-1209. (Pubitemid 32947949)
27. Weaver JGR, Rouse MS, Steckelberg JM, Badley AD. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J 2004;18:1185-1191. (Pubitemid 39006880)
28. Li QR, Zhang Q, Wang M, Zhao SM, Xu GW, Li JS. n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. Mol Immunol 2008;45:1356-1365. (Pubitemid 350299478)
29. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164-6172. (Pubitemid 37467239)